CARDINAL HEALTH, INC. for CARDINAL HEALTH INC
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Civil Rights/Civil Liberties CIV
Equality Act, H.R. 5
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Alcohol and Drug Abuse ALC
General issues regarding prescription drug abuse
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Budget/Appropriations BUD
FY2020 Appropriations for Strategic National Stockpile funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Tariff (miscellaneous tariff bills) TAR
Exclusion of health care related products in proposed section 301 tariffs. Educate on potential impact of tariffs on goods from Mexico.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Energy/Nuclear ENG
American Medical Isotopes Production Act of 2012: Section 2: Improving the Reliability of Domestic Medical Isotope Supply- implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Defense DEF
Changes to the House and Senate National Defense Authorization Acts, Section 801 regarding federal contracting - implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Health Issues HCR
Issues related to the RFI on the HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Medical/Disease Research/Clinical Labs MED
Medical Device Tax Repeal - H.R. 2207, S. 692, Protect Medical Innovation Act of 2019; H.R. 1865, Further Consolidated Appropriations Act, 2020
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| ANGELEINE COMTE | — |
| NATHAN CONSTABLE | — |
| REBECCA MCGRATH | — |
| ALI MURPHY | — |
| HANNAH RICHARDSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.